MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Infectious Disease_Hepatitis
Aligos Therapeutics, Inc. (NASDAQ: ALGS)*
Attachments
Home - ALIGOS Therapeutics
Parents
2024: Biopharma Layoff Tracker 2024: C4, Affimed, Senti and More Cut Staff
Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Architects: Infectious Disease _ Virology_Antiviral, Antivirus
Architects: Infectious Disease_Hepatitis
Industry: Northern California & Silicon Valley
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Children
Finance & Acquisitions: Aligos Therapeutics
Founded 2018
Key People: Aligos Therapeutics
Organization & Developments: Aligos Therapeutics
South San Francisco, California